Trial Profile
A trial of NK cells targeted to breast cancer.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 15 Feb 2022
Price :
$35
*
At a glance
- Drugs CST 101 (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- 21 Nov 2016 New trial record